Ra Capital Management, L.p.
Artiva Biotherapeutics, Inc. · Director, 10% Owner
Ra Capital Management, L.p. is listed in public filings as director, 10 percent owner:. This Ra Capital Management, L.p. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Artiva Biotherapeutics, Inc. (ARTV), Wave Life Sciences Ltd. (WVE), Vor Biopharma Inc. (VOR), Tyra Biosciences, Inc. (TYRA), and Sionna Therapeutics, Inc. (SION). Investors use Ra Capital Management, L.p.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $60k94.4k shares | SellMay 12, 2026 | $0.64 | $0.456 | |
| $55k81.7k shares | SellMay 11, 2026 | $0.67 | $0.456 | |
| $250k351.5k shares | SellMay 8, 2026 | $0.71 | $0.456 | |
| $1.4M91.7k shares | SellDec 8, 2025 | $14.98 | $6.78 | |
| $39M2.7M shares | SellDec 8, 2025 | $14.28 | $6.78 | |
| $18M1.4M shares | SellDec 8, 2025 | $13.33 | $6.78 | |
| $465k213.1k shares | BuyDec 11, 2025 | $2.18 | $11.34 | |
| $290k101.5k shares | BuyDec 12, 2025 | $2.86 | $11.34 | |
| $25k7.1k shares | BuyJan 5, 2026 | $3.50 | $11.34 | |
| $2202.2M shares | BuyFeb 26, 2026 | $0.0001 | $21.27 | |
| $4.8M300k shares | BuyFeb 26, 2026 | $16.00 | $21.27 | |
| $2172.2M shares | BuyMay 11, 2026 | $0.0001 | $8.00 | |
| $75M6.5M shares | BuyMay 11, 2026 | $11.52 | $8.00 |